Patents by Inventor Maria Elizabeth DE SOUZA RODRIGUES

Maria Elizabeth DE SOUZA RODRIGUES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating complications related to acute or chronic hyperglycemia
    Patent number: 11793836
    Abstract: The disclosure concerns a method of treating complications of acute or chronic hyperglycemia and/or diet-induced obesity comprising: (i) determining whether a patient suffers from complications related to acute or chronic hyperglycemia and/or diet induced obesity, and if so, (ii) administering to the patient in need thereof a selective inhibitor of soluble TNF-? but not transmembrane TNF-?. For purposes herein, complications of acute or chronic hyperglycemia and/or diet-induced obesity include: diabetes mellitus, insulin resistance, hepatic steatosis, non-alcoholic hepatic steatosis, fibrotic liver disease, vascular disease, and chronic intestinal inflammation.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: October 24, 2023
    Assignees: INmune Bio Inc, EMORY UNIVERSITY
    Inventors: Maria Elizabeth De Souza Rodrigues, Maria de Lourdes Gamez Tansey, Christopher J. Barnum, Raymond J. Tesi, Dean P. Jones, Douglas I. Walker
  • METHOD FOR TREATING COMPLICATIONS RELATED TO ACUTE OR CHRONIC HYPERGLYCEMIA
    Publication number: 20200289576
    Abstract: The disclosure concerns a method of treating complications of acute or chronic hyperglycemia and/or diet-induced obesity comprising: (i) determining whether a patient suffers from complications related to acute or chronic hyperglycemia and/or diet induced obesity, and if so, (ii) administering to the patient in need thereof a selective inhibitor of soluble TNF-? but not transmembrane TNF-?. For purposes herein, complications of acute or chronic hyperglycemia and/or diet-induced obesity include: diabetes mellitus, insulin resistance, hepatic steatosis, non-alcoholic hepatic steatosis, fibrotic liver disease, vascular disease, and chronic intestinal inflammation.
    Type: Application
    Filed: September 27, 2018
    Publication date: September 17, 2020
    Applicants: INmune Bio, Inc., EMORY UNIVERSITY
    Inventors: Maria Elizabeth DE SOUZA RODRIGUES, Malu G. TANSEY, Christopher J. BARNUM, Raymond J. TESI